한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제27권5호
  • /
  • Pages.553-558
  • /
  • 2010
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지

개의 신장에 있어서 Ascorbic Acid에 의한 허혈/재관류 손상의 감소에 관한 연구

Attenuation of Renal Ischemia-Reperfusion (I/R) Injury by Ascorbic Acid in the Canine Nephrotomy

  • 김종만 (충남대학교 수의과대학) ;
  • 이재연 (충남대학교 수의과대학) ;
  • 정성목 (충남대학교 수의과대학) ;
  • 박창식 (충남대학교 동물자원학부 형질전환복제돼지연구센터) ;
  • 김명철 (충남대학교 수의과대학)
  • Kim, Jong-Man (College of Veterinary Medicine, Chungnam National University) ;
  • Lee, Jae-Yeon (College of Veterinary Medicine, Chungnam National University) ;
  • Jeong, Seong-Mok (College of Veterinary Medicine, Chungnam National University) ;
  • Park, Chang-Sik (Division of Animal Science & Resources, Research Center for Transgenic Cloned Pigs, Chungnam National University) ;
  • Kim, Myung-Cheol (College of Veterinary Medicine, Chungnam National University)
  • 심사 : 2010.09.27
  • 발행 : 2010.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

본 연구의 목적은 개의 신장 절개술 모델에서 ascorbic acid를 전처치 하거나 관주 및 흡인시에 있어서, 허혈/재관류 손상의 감소와 신장 기능의 회복에 대한 효과를 평가하는데 있다. 성숙 잡종견 9두에서 신장절개술을 실시하였으며, hepa-saline 관주 및 흡인군와 ascorbic acid로 전처치 한 후 hepa-saline 관주 및 흡인한 군을 각각 실험군 1, 2로 놓았다. 신기능 검사와 항산화 효소 검사를 위해 신장절개술 후 0, 1, 3, 5, 7일에 혈액 샘플을 채취하였다. 그리고 7일 후 TNF-alpha, INF-gamma 검사를 위해 신장을 적출 보관하였다. 신장의 기능 검사에서 처치군 1과 2는 재관류 후 3, 5 그리고 7일째에 대조군과 비교하여 유의성 있게 감소 하였으며(p < 0.05), 처치군 2는 재관류 후 3일째에서 처치군 1과 비교하여 유의성있게 감소하였다(p < 0.05). 혈장에서의 항산화 효소의 활성치는 처치군 1과 2는 재관류 후 3, 5 그리고 7일째에 대조군과 비교하여 유의성 있게 증가 하였으며(p < 0.05), 처치군 2는 재관류 후 3일째에서 처치군 1과 비교하여 유의성있게 증가하였다(p < 0.05). TNF-alpha는 감소하고, INF-gamma는 증가하였다. 본 연구의 결과 신장의 관주 및 흡인의 과정은 신장의 관주 및 흡인의 과정은 신장의 허혈 및 재관류 손상을 감소 시키는 데에 효과가 있음을 시사하며, 또한, 외인성 ascorbic acid의 투여는 개의 신장 절개술에서 허혈 및 재관류의 손상을 감소시키며 신기능의 회복에 효과가 있음을 시사한다.

The purpose of this study was to investigate the effects of premedicated ascorbic acid and hepa-saline irrigation/aspiration on attenuation of ischemia-reperfusion (I/R) injury and recovery of renal function in canine nephrotomy model. In the canine model, nine mixed dogs were subjected to renal nephrotomy with premedicated ascorbic acid and hepa-saline irrigation-aspiration (treatment group 2), and only hepa-saline irrigation-aspiration (treatment group 1). The level of renal function and antioxidant enzymes after nephrotomy were measured. And the expression pattern of TNF-${\alpha}$ and INF-${\gamma}$ was examined in the renal tissue at $7^{th}$ day after nephrotomy. BUN and creatinine levels significantly decreased in the treatment group 1 and 2 compared to that of control group at the $3^{rd}$, 5th and $7^{th}$ day after reperfusion (p < 0.05). And, there was significant difference between treatment group 1 and 2 at the $3^{rd}$ day after reperfusion (p < 0.05). The activities of antioxidant enzymes in plasma was significantly increased in the treatment group 1 and 2 compared to that of control group at the $3^{rd}$, $5^{th}$ and $7^{th}$ day after reperfusion (p < 0.05). And, there was significant difference between treatment group 1 and 2 at the $3^{rd}$ day after reperfusion (p < 0.05). TNF-${\alpha}$ was decreased and INF-${\gamma}$ was increased in treatment groups. The result of this study suggested that irrigation-aspiration has effects on attenuation of renal ischemia-reperfusion injury, and the exogenous ascorbic acid has a role in the attenuation of renal ischemia-reperfusion injury and recovery of renal function in canine nephrotomy model.

키워드

참고문헌

  1. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 1991; 5: 733-742. https://doi.org/10.1007/BF00857888
  2. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997; 29: 207-216. https://doi.org/10.1016/S0735-1097(97)86479-0
  3. Baud L, Ardaillou R. Involvement of reactive oxygen species in kidney damage. Br Med Bull 1993; 49: 621-629. https://doi.org/10.1093/oxfordjournals.bmb.a072635
  4. Brasile L, Stubenitsky BM, Booster MH, Lindell S, Araneda D, Buck C, Bradfield j, haisch CE, Kootstra G. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 2002; 73: 897-901. https://doi.org/10.1097/00007890-200203270-00011
  5. Brown NO, Parks JL, Greene RW. Canine urolithiasis: Retrospective analysis of 438 cases. J Am Vet Med Assoc 1977; 170: 414-417.
  6. Bryan CF, Luger AM, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF 3rd, Warady BA, Aeder MI, Helling TS. Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation 2001; 71: 875-879. https://doi.org/10.1097/00007890-200104150-00009
  7. Buffington CAT, Chew DJ: Calcium oxalate urolithiasis in cats. J Endourol 1999; 13: 659-662. https://doi.org/10.1089/end.1999.13.659
  8. Bulkley GB. Free radical-mediated reperfusion injury: a selective review. Br J Cancer Suppl 1987; 8: 66-73.
  9. Daemen MA, van de Ven MW, Heineman E, Buurman WA. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 1999; 27: 792-800.
  10. Daemen MA, van't Veer C, Wolfs TG, Buurman WA. Ischemia/reperfusion-induced IFN-gamma up-regulation. J Immunol 1999; 162: 5506-5510.
  11. Demirbas M, Samli M, Aksoy Y, Guler C, Kilinc A, Dincel C. Comparison of changes in tissue osidative-stress markers in experimental model of open, laparoscopic and retroperitoneoscopic donor nephrectomy. J Endourol 2004; 18: 105-108. https://doi.org/10.1089/089277904322836758
  12. Donnahoo KK, Melsrum DR, Shenkar R, Chung CS, Abraham E, Harken AH. Eary renal ischemia, with or without reperfusion, axtivates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 2000; 163: 1328-1332. https://doi.org/10.1016/S0022-5347(05)67772-5
  13. Donnahoo KK, Neng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal isxhemia-reperfusion. Am J Physiol 1999; 277: R922-929.
  14. Donnahoo KK, Shames BD, Harken AH, Meldrum DR: Teh role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162: 196-203. https://doi.org/10.1097/00005392-199907000-00068
  15. Gahring DR, Crowe DT, Powers TE, Powers JD, Krakowka S,Wilson GP. Comparative renal function studies of nephrotomy closure with and without sutures in dogs. J Am Vet Med Assoc 1977; 171: 537-540.
  16. Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci 1997; 92: 361-365. https://doi.org/10.1042/cs0920361
  17. Gianello P, Saliez A, Bufkens X, pettinger R, Misseleyn D, Hori S, Malfory B. EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kidneys from ischemiareperfusion- induced damage. Transplantation 1996; 62: 1664-1666. https://doi.org/10.1097/00007890-199612150-00022
  18. Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AA, Panichi V, Filippi C, Bertelli A. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 2001; 37: 262-270. https://doi.org/10.1097/00005344-200103000-00004
  19. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565-572. https://doi.org/10.1097/00007890-199502270-00022
  20. Heeman U, Szabo A, Hamaar P, Muller V, Witzke O, Lutz J, Philipp T. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury. Am J Pathol 2000; 156: 287-293. https://doi.org/10.1016/S0002-9440(10)64729-3
  21. Jefayri MK, Grace PA, Mathie RT. Attenuation of reperfusion injury by renal ischaemic preconditioning: the role of nitric oxide. BJU Int 2000; 85: 1007-1013. https://doi.org/10.1046/j.1464-410x.2000.00678.x
  22. Kitada H, Sugitani A, Yamamoto H, Otomo N, Okabe Y, Inoue S, Nishiyama K, Morisaki T, Tanaka M. Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs. Surgery 2002; 131: 654-662. https://doi.org/10.1067/msy.2002.124629
  23. Lee CM, Carter JT, Randall HB, Hiose R, Stock PG, Melzer JS, Dafoe DC, Freise CE, Alfrey EJ. The effect of age and prolonged cold ischemia times on the national allocation of cadaveric renal allografts. J Surg Res 2000; 91: 83-88. https://doi.org/10.1006/jsre.2000.5921
  24. Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol 1998; 18: 505-18.
  25. Nita DA, Nita V, Spulber S, Moldovan M, Popa DP, zagrean AM, Zagrean L. Oxidative damage followingcerebral ischemia depends on reperfusion- a biochemical study in rat. J Cell Mol Med 2001; 5: 163-170. https://doi.org/10.1111/j.1582-4934.2001.tb00149.x
  26. Rabb H, O'Meara YM, Aaderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 1997; 51: 1463-1468, https://doi.org/10.1038/ki.1997.200
  27. Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem 1993; 268: 1304-1309.
  28. Salahudeen AK, Wang C, Kanji VK. Comparative study of the effect of 21-aminosteroid and vitamin E on models of acute renal injury. Free Radic Biol Med 1996; 21: 691-697. https://doi.org/10.1016/0891-5849(96)00126-8
  29. Sakura H, Ammala C, Smith PA, Gribble FM, Ashcroft FM. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle. FEBS Lett 1995; 377: 338-344. https://doi.org/10.1016/0014-5793(95)01369-5
  30. Sekhon CS, Sekhon BK, Singh I, Orak JK, Singh AK. Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy. J Nephrol 2003; 16: 63-74.
  31. Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997; 82: 291-295. https://doi.org/10.1113/expphysiol.1997.sp004024
  32. Uysal F, Girgin FK, Tuzun S, Aldemir S, Sozmen EY. Effect of vitamin E on antioxidant enzymes and nitric oxide in ischemia-reperfused kidney injury. Biochem Mol Biol Int 1998; 44: 1255-1263.
  33. Wang S, Berge GE, Hoem NO, Sund RB. Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid. Res Vet Sci 2001; 71: 27-32. https://doi.org/10.1053/rvsc.2001.0480
  34. Yokozawa T, Fujii H, Kosuna K, Nonaka G. Effects of buckwheat in a renal ischemia-reperfusion model. Biosci Biotechnol Biochem 2001; 65: 396-400. https://doi.org/10.1271/bbb.65.396